KMT2A and leukemia: The adenosine derivative (29) and its phenylurea analog (31) (EPZ004777) [101] showed very good inhibition and specificity for DOT1L, reduced leukemia-relevant gene expression and induced differentiation of MLL (mixed-lineage leukemia) leukemia cells.